Dana-Farber registers Phase I/II trial of Tango's TNG462 with lorlatinib in ALK+ NSCLCNov 16Trial updatelorlatinibPfizer
Seagen/Pfizer's MOUNTAINEER-03 trial for HER2+ colorectal cancer remains active, not recruitingNov 16Trial updatebevacizumabPfizer
The company: FDA grants accelerated approval to tucatinib with trastuzumab for colorectal cancerNov 12Regulatory decisionpertuzumab-dpzbpertuzumab, trastuzumab, and hyaluronidase-zzxfRecord notice
Pfizer registers Phase 3 marstacimab hemophilia trial and elranatamab myeloma comparison studyNov 12Weekly roundup, 10 itemsabrocitinibberobenatide
Arbutus gets FDA clinical hold lifted on AB-101, expands Pfizer/BioNTech patent suitsNov 10Quarterly updateArbutus Biopharma CorpPfizer
FDA's traditional approval of encorafenib followed earlier accelerated approval in same indicationNov 9Regulatory decisionencorafenibPfizerUpdated
FDA converts Tivdak approval to full approval for cervical cancerNov 9Regulatory decisionPfizertisotumab vedotinUpdated
Pfizer adds second Phase 3 berobenatide knee osteoarthritis trial, completes Phase 2b VESPER-3Nov 6Weekly roundup, 13 itemsberobenatidemarstacimab-hncqUpdated
Pfizer raises 2026 guidance after Q3, reports pipeline progress and new CFONov 3Quarterly updateBioNTech SEC4 Therapeutics, Inc.
Pfizer ends phase 2 extension study of PF-07868489 in pulmonary arterial hypertensionNov 2Trial updatePF-07868489Pfizer
Roche group registers Phase III UC trial, GA-AMD study; AD extension stays activeOct 30Weekly roundup, 7 itemsafimkibartastegolimab
UIC registers Phase 1 trial of Pfizer's elranatamab in plasmablastic lymphomaOct 30Weekly roundup, 11 itemsAstellas Pharmaatirmociclib
Pfizer terminates TACTIVE-U Sub-Study C of vepdegestrant plus samuraciclibOct 27Trial updatePfizerRigel Pharmaceuticals Inc
FDA approves talazoparib plus enzalutamide for a new prostate cancer populationOct 26Regulatory decisionenzalutamidePfizer
Pfizer registers four studies: elranatamab, berobenatide, tilrekimig, and completed etrasimod trialOct 23Weekly roundup, 14 itemsabrocitinibatirmociclibUpdated
FDA lifts clinical hold on Arbutus's AB-101 IND applicationOct 22Regulatory decisionArbutus Biopharma Corplinezolid
Pfizer wins two FDA labeling supplements; obesity trial roster unchangedOct 15Weekly roundup, 8 itemsberobenatidemethotrexate